New members include former officials from the U.S. Department of Energy, Federal Bureau of Investigation, and U.S. Marine CorpsSANTA CLARA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Netskope, (NASDAQ: NTSK) a leader in modern security and networking for the cloud and AI era, today announced the addition of three veteran United States federal government leaders to its U.S. Federal Advisory Board. These experienced executives will provide strategic guidance on Netskope’s go-to-market strategy and efforts in U ...

Core Insights - Figure Technology Solutions has announced a $25 million strategic investment from Ondo Finance in its $YLDS stablecoin, enhancing the yield source for Ondo's flagship tokenized fund, OUSG [1][2][3] - The partnership aims to strengthen the position of $YLDS in the tokenized real-world assets market and accelerate institutional adoption of on-chain finance [3][5] Company Overview - Figure Technology Solutions operates a blockchain-based capital marketplace, having originated over $19 billion in home equity financing, making it the largest non-bank provider in this sector [4][5] - The company’s ecosystem includes various components such as Figure Connect, a consumer credit marketplace, and Democratized Prime, an on-chain lending platform [4] Product Details - $YLDS is a registered security that pays interest to holders and is backed by the same assets as GENIUS Act stablecoins, providing a unique utility in the market [2][4] - The integration of $YLDS into OUSG's yield strategy is expected to diversify and institutionalize the ecosystem supporting Ondo's products [3][4] Strategic Importance - The investment from Ondo Finance is seen as a natural connection due to both companies' strong presence in tokenized Real-World Assets (RWAs) [2][3] - This collaboration is positioned to enhance Figure's expansion efforts, particularly around its DeFi platform, Democratized Prime [2][3]

Core Insights - Chaince Digital Holdings Inc. has entered a non-binding Strategic Cooperation Framework Agreement with ZJK Industrial Co., Ltd. to establish a precision components R&D and manufacturing gigafactory in the U.S. aimed at serving the AI and semiconductor industries [1][2] Investment and Financial Commitment - The companies plan to invest up to $200 million through various projects, utilizing both self-owned capital and external fundraising to strengthen the U.S. high-end manufacturing ecosystem [2] Gigafactory Focus and Operations - The gigafactory will concentrate on high-value, non-restricted precision components across multiple technology categories, excluding restricted semiconductor segments like wafer fabrication and chip design [3] - A Delaware joint venture will be formed to operate the gigafactory, overseeing all operations from R&D to full-scale production [5] Competitive Advantages and Management - The collaboration aims to enhance the made-in-America vision by combining ZJK's manufacturing expertise with Chaince Digital's strengths in capital markets and digital technologies [6] - The joint venture will feature a U.S.-based management team with executives from leading American companies, targeting key industries such as AI hardware and electric vehicles [6] Product Focus - The gigafactory will produce components for AI end-devices, semiconductor equipment, liquid-cooling systems, new energy vehicles, smart wearables, and other consumer electronics [7] Strategic Advisory Role - Chaince Securities has been appointed as ZJK's capital markets strategic advisor for five years, focusing on capital markets strategy and financing needs [4][8] Leadership Statements - ZJK's CEO emphasized that the partnership will enhance their manufacturing footprint in the U.S. and support the Made in America initiative [9] - Chaince Digital's Chief Strategy Officer expressed commitment to leveraging their strengths to support the gigafactory's development [9]

Core Insights - Stereotaxis is participating in the Piper Sandler 37th Annual Healthcare Conference, with CEO David Fischel scheduled for a discussion and one-on-one meetings on December 3, 2025 [1][2] Company Overview - Stereotaxis is a leader in surgical robotics for minimally invasive endovascular interventions, focusing on the development of robotic systems and solutions that enhance patient care and operational efficiency [2] - The company's technology has been utilized to treat over 150,000 patients globally, indicating a significant market presence [2]

Core Insights - OneMedNet Corporation has received strong validation for its redesigned data exploration and cohort-building platform from customers and prospects at ISPOR Europe, showcasing its commercial relevance and competitive differentiation [2][3] - The platform, built on Palantir Foundry and AIP, allows research teams to determine cohort feasibility in minutes instead of weeks, enhancing accuracy and efficiency [3][4] Company Overview - OneMedNet operates the largest global live, regulatory-grade AI-ready Real-World Data (RWD) network, encompassing over 2,130 provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images [2][4] - The company aims to revolutionize the use of Real-World Data, providing insights that drive innovation in drug development, medical devices, and AI applications [4][5] Technological Advancements - Key advancements of the new platform include significantly faster cohort feasibility, AI-driven natural-language search for complex discovery tasks, and real-time availability of longitudinal insights [7] - The platform supports subscription workflows, which is expected to contribute to recurring-revenue growth for the company [7]

Core Insights - Clearmind Medicine Inc. has received a positive recommendation from its independent Data and Safety Monitoring Board (DSMB) to continue its Phase I/IIa clinical trial for CMND-100, a non-hallucinogenic neuroplastogen aimed at treating Alcohol Use Disorder (AUD) [1][2][3] Group 1: Clinical Trial Details - The ongoing multinational, multi-center trial is assessing the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of CMND-100 in reducing alcohol cravings and consumption among individuals with moderate to severe AUD [2] - The DSMB's review highlighted a favorable safety profile with no serious adverse events reported and general good tolerability across all participants [6] Group 2: Company Statements and Future Outlook - The CEO of Clearmind expressed confidence in CMND-100's safety and therapeutic potential, indicating that the positive interim data positions the company to accelerate enrollment in the trial [3] - The DSMB was established in 2023 to ensure patient safety and data integrity throughout the trial, reflecting the company's commitment to ethical clinical development [3] Group 3: Company Background and Intellectual Property - Clearmind is focused on developing novel psychedelic-derived therapeutics to address significant health issues, including AUD, with the goal of commercializing these compounds as regulated medicines [4] - The company holds an intellectual property portfolio consisting of nineteen patent families, including 31 granted patents, and plans to seek additional patents as warranted [5]

Core Viewpoint - Fulton Financial Corporation is acquiring Blue Foundry Bancorp in an all-stock transaction valued at approximately $243 million, enhancing Fulton's presence in the northern New Jersey market and expected to be accretive to earnings and tangible book value [2][3][4]. Group 1: Transaction Details - The merger agreement stipulates that each share of Blue Foundry common stock will be exchanged for 0.6500 shares of Fulton common stock, valuing Blue Foundry at $11.67 per share based on Fulton's share price of $17.96 as of November 21, 2025 [2]. - The transaction is anticipated to close in the second quarter of 2026, pending regulatory approvals and stockholder approval from Blue Foundry [4]. Group 2: Strategic Implications - This acquisition is part of Fulton's strategy to accelerate growth in the attractive northern New Jersey market, with expectations of over 5% accretion to first full-year earnings and immediate accretion to tangible book value per share [3]. - The merger aims to combine the strengths of both community-focused banks, enhancing customer service and expanding the range of banking solutions available to a larger customer base [5]. Group 3: Community Commitment - Fulton will contribute $1.5 million to the Fulton Forward Foundation to support nonprofit community organizations in New Jersey as part of the transaction [5]. Group 4: Company Backgrounds - Fulton Financial Corporation is a $32 billion asset financial holding company providing various financial services across multiple states, including Pennsylvania, Maryland, Delaware, New Jersey, and Virginia [7]. - Blue Foundry Bancorp operates Blue Foundry Bank, serving communities in New Jersey with a commitment to innovative banking solutions and a history of over 145 years [9].

The Sustainable Green Team, LTD. SGTM Restore™ ORLANDO, Fla., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sustainable Green Team, Ltd. (OTC: SGTM) today filed three additional U.S. provisional patent applications, bringing its total intellectual property portfolio to more than 25 filings (23 provisional), multiple issued patents, and a comprehensive trademark suite. These three new filings are the latest chapter in a lifetime of commitment to the tree-care, arborist, and landscape industry. For two decades SGTM ...

Havila Kystruten AS ("Havila Kystruten" or the "Company") announces that the previously disclosed EUR 456 million refinancing has now been completed. Closing took place on 24 November 2025 following satisfaction of all customary conditions. The refinancing has been implemented through a 15-year financial lease facility provided by a subsidiary of Havila Holding AS. All outstanding bond debt and shareholder loans have been fully repaid at closing, and no new equity or convertible instruments have been issued ...

Core Insights - UNICOS has launched an expansion of its easy-application makeup line, introducing upgraded tools that align with its "Simple. Speedy. Special." philosophy [1][12] - The brand has gained significant attention through organic growth, leveraging social media platforms like TikTok to showcase its products [8][9] Product Overview - The UNICOS Freckle Pen, a 2-in-1 tool, allows users to define freckles and apply blush in one step, emphasizing ease of use and blendability [4] - The UNICOS Eyelash Stamp is designed for beginners, featuring a dual-end design that includes a fine eyeliner tip and a lower lash stamp for quick application [5] Brand Philosophy - UNICOS promotes the idea that beauty should be easy and empowering, encouraging users to express themselves without complicated techniques [3][12] - The brand's minimal aesthetic, characterized by its signature purple color, symbolizes strength and individuality, fostering a community around self-expression [9] Marketing Strategy - UNICOS has built its following organically, with viral videos showcasing its products generating millions of views on social media [8] - Influencers have played a key role in promoting the brand, with positive reviews highlighting the effectiveness and ease of use of the Freckle Pen and Lash Stamp [8] Future Directions - The upcoming product line will focus on multifunctional facial tools and optimized makeup settings, aiming to help users achieve professional results quickly [12][16] - UNICOS continues to emphasize its core belief in simplicity and speed in makeup application, making beauty accessible to all [12]